Table of Content

1 Study Coverage
1.1 Heart Failure Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type
1.4.2 ACEI
1.4.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market by Application
1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Heart Failure Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Heart Failure Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Heart Failure Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Heart Failure Drugs Regions by Sales
2.4.1 Global Top Heart Failure Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Heart Failure Drugs Regions by Sales (2022-2027)
2.5 Global Top Heart Failure Drugs Regions by Revenue
2.5.1 Global Top Heart Failure Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Heart Failure Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Heart Failure Drugs Sales by Manufacturers
3.1.1 Global Top Heart Failure Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Heart Failure Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Heart Failure Drugs Sales in 2020
3.2 Global Heart Failure Drugs Revenue by Manufacturers
3.2.1 Global Top Heart Failure Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Heart Failure Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Heart Failure Drugs Revenue in 2020
3.3 Global Heart Failure Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Heart Failure Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Heart Failure Drugs Sales by Type
4.1.1 Global Heart Failure Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Heart Failure Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2016-2027)
4.2 Global Heart Failure Drugs Revenue by Type
4.2.1 Global Heart Failure Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Heart Failure Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Heart Failure Drugs Price by Type
4.3.1 Global Heart Failure Drugs Price by Type (2016-2021)
4.3.2 Global Heart Failure Drugs Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Heart Failure Drugs Sales by Application
5.1.1 Global Heart Failure Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Heart Failure Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2016-2027)
5.2 Global Heart Failure Drugs Revenue by Application
5.2.1 Global Heart Failure Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Heart Failure Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Heart Failure Drugs Price by Application
5.3.1 Global Heart Failure Drugs Price by Application (2016-2021)
5.3.2 Global Heart Failure Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Heart Failure Drugs Market Size by Type
6.1.1 North America Heart Failure Drugs Sales by Type (2016-2027)
6.1.2 North America Heart Failure Drugs Revenue by Type (2016-2027)
6.2 North America Heart Failure Drugs Market Size by Application
6.2.1 North America Heart Failure Drugs Sales by Application (2016-2027)
6.2.2 North America Heart Failure Drugs Revenue by Application (2016-2027)
6.3 North America Heart Failure Drugs Market Size by Country
6.3.1 North America Heart Failure Drugs Sales by Country (2016-2027)
6.3.2 North America Heart Failure Drugs Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Heart Failure Drugs Market Size by Type
7.1.1 Europe Heart Failure Drugs Sales by Type (2017-2027)
7.1.2 Europe Heart Failure Drugs Revenue by Type (2017-2027)
7.2 Europe Heart Failure Drugs Market Size by Application
7.2.1 Europe Heart Failure Drugs Sales by Application (2017-2027)
7.2.2 Europe Heart Failure Drugs Revenue by Application (2017-2027)
7.3 Europe Heart Failure Drugs Market Size by Country
7.3.1 Europe Heart Failure Drugs Sales by Country (2017-2027)
7.3.2 Europe Heart Failure Drugs Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Heart Failure Drugs Market Size by Type
8.1.1 Asia Pacific Heart Failure Drugs Sales by Type (2018-2027)
8.1.2 Asia Pacific Heart Failure Drugs Revenue by Type (2018-2027)
8.2 Asia Pacific Heart Failure Drugs Market Size by Application
8.2.1 Asia Pacific Heart Failure Drugs Sales by Application (2018-2027)
8.2.2 Asia Pacific Heart Failure Drugs Revenue by Application (2018-2027)
8.3 Asia Pacific Heart Failure Drugs Market Size by Region
8.3.1 Asia Pacific Heart Failure Drugs Sales by Region (2018-2027)
8.3.2 Asia Pacific Heart Failure Drugs Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Heart Failure Drugs Market Size by Type
9.1.1 Latin America Heart Failure Drugs Sales by Type (2019-2027)
9.1.2 Latin America Heart Failure Drugs Revenue by Type (2019-2027)
9.2 Latin America Heart Failure Drugs Market Size by Application
9.2.1 Latin America Heart Failure Drugs Sales by Application (2019-2027)
9.2.2 Latin America Heart Failure Drugs Revenue by Application (2019-2027)
9.3 Latin America Heart Failure Drugs Market Size by Country
9.3.1 Latin America Heart Failure Drugs Sales by Country (2019-2027)
9.3.2 Latin America Heart Failure Drugs Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Heart Failure Drugs Market Size by Type
6.1.1 Middle East and Africa Heart Failure Drugs Sales by Type (2016-2027)
6.1.2 Middle East and Africa Heart Failure Drugs Revenue by Type (2016-2027)
6.2 Middle East and Africa Heart Failure Drugs Market Size by Application
6.2.1 Middle East and Africa Heart Failure Drugs Sales by Application (2016-2027)
6.2.2 Middle East and Africa Heart Failure Drugs Revenue by Application (2016-2027)
6.3 Middle East and Africa Heart Failure Drugs Market Size by Country
6.3.1 Middle East and Africa Heart Failure Drugs Sales by Country (2016-2027)
6.3.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Novartis Heart Failure Drugs Product Description
11.1.5 Novartis Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Heart Failure Drugs Product Description
11.2.5 Pfizer Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 AstraZeneca Heart Failure Drugs Product Description
11.3.5 AstraZeneca Related Developments
11.4 Hikma
11.4.1 Hikma Corporation Information
11.4.2 Hikma Overview
11.4.3 Hikma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Hikma Heart Failure Drugs Product Description
11.4.5 Hikma Related Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Teva Heart Failure Drugs Product Description
11.5.5 Teva Related Developments
11.6 Cipla
11.6.1 Cipla Corporation Information
11.6.2 Cipla Overview
11.6.3 Cipla Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Cipla Heart Failure Drugs Product Description
11.6.5 Cipla Related Developments
11.7 Merck & Co.
11.7.1 Merck & Co. Corporation Information
11.7.2 Merck & Co. Overview
11.7.3 Merck & Co. Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Merck & Co. Heart Failure Drugs Product Description
11.7.5 Merck & Co. Related Developments
11.8 Amgen
11.8.1 Amgen Corporation Information
11.8.2 Amgen Overview
11.8.3 Amgen Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Amgen Heart Failure Drugs Product Description
11.8.5 Amgen Related Developments
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Overview
11.9.3 Roche Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Roche Heart Failure Drugs Product Description
11.9.5 Roche Related Developments
11.10 Sun Pharma
11.10.1 Sun Pharma Corporation Information
11.10.2 Sun Pharma Overview
11.10.3 Sun Pharma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Sun Pharma Heart Failure Drugs Product Description
11.10.5 Sun Pharma Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Novartis Heart Failure Drugs Product Description
11.1.5 Novartis Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Heart Failure Drugs Value Chain Analysis
12.2 Heart Failure Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Heart Failure Drugs Production Mode & Process
12.4 Heart Failure Drugs Sales and Marketing
12.4.1 Heart Failure Drugs Sales Channels
12.4.2 Heart Failure Drugs Distributors
12.5 Heart Failure Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Heart Failure Drugs Industry Trends
13.2 Heart Failure Drugs Market Drivers
13.3 Heart Failure Drugs Market Challenges
13.4 Heart Failure Drugs Market Restraints

14 Key Findings in The Global Heart Failure Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Heart Failure Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of ACEI
Table 3. Major Manufacturers of Angiotensin II Receptor Blockers
Table 4. Major Manufacturers of ARNIs
Table 5. Major Manufacturers of Beta Blockers
Table 6. Major Manufacturers of Aldosterone Antagonists
Table 7. Major Manufacturers of Diuretics
Table 8. Global Heart Failure Drugs Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Heart Failure Drugs Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 10. Global Heart Failure Drugs Sales by Region (2016-2021) & (MT)
Table 11. Global Heart Failure Drugs Sales Market Share by Region (2016-2021)
Table 12. Global Heart Failure Drugs Sales by Region (2016-2021) & (MT)
Table 13. Global Heart Failure Drugs Sales Market Share by Region (2022-2027)
Table 14. Global Heart Failure Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 15. Global Heart Failure Drugs Revenue Market Share by Region (2016-2021)
Table 16. Global Heart Failure Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 17. Global Heart Failure Drugs Revenue Market Share by Region (2022-2027)
Table 18. Global Heart Failure Drugs Sales by Manufacturers (2016-2021) & (MT)
Table 19. Global Heart Failure Drugs Sales Share by Manufacturers (2016-2021)
Table 20. Global Heart Failure Drugs Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 21. Global Heart Failure Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Heart Failure Drugs Price by Manufacturers 2016-2021 (USD/MT)
Table 23. Global Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Heart Failure Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heart Failure Drugs as of 2020)
Table 25. Heart Failure Drugs Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Heart Failure Drugs Product Offered
Table 27. Date of Manufacturers Enter into Heart Failure Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 30. Global Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 31. Global Heart Failure Drugs Sales Share by Type (2016-2021)
Table 32. Global Heart Failure Drugs Sales Share by Type (2022-2027)
Table 33. Global Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 34. Global Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 35. Global Heart Failure Drugs Revenue Share by Type (2016-2021)
Table 36. Global Heart Failure Drugs Revenue Share by Type (2022-2027)
Table 37. Heart Failure Drugs Price by Type (2016-2021) & (USD/MT)
Table 38. Global Heart Failure Drugs Price Forecast by Type (2022-2027) & (USD/MT)
Table 39. Global Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 40. Global Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 41. Global Heart Failure Drugs Sales Share by Application (2016-2021)
Table 42. Global Heart Failure Drugs Sales Share by Application (2022-2027)
Table 43. Global Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 44. Global Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 45. Global Heart Failure Drugs Revenue Share by Application (2016-2021)
Table 46. Global Heart Failure Drugs Revenue Share by Application (2022-2027)
Table 47. Heart Failure Drugs Price by Application (2016-2021) & (USD/MT)
Table 48. Global Heart Failure Drugs Price Forecast by Application (2022-2027) & (USD/MT)
Table 49. North America Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 50. North America Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 51. North America Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 52. North America Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 53. North America Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 54. North America Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 55. North America Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 56. North America Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 57. North America Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 58. North America Heart Failure Drugs Sales by Country (2022-2027) & (MT)
Table 59. North America Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 60. North America Heart Failure Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 61. Europe Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 62. Europe Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 63. Europe Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 64. Europe Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 65. Europe Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 66. Europe Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 67. Europe Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 68. Europe Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 69. Europe Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 70. Europe Heart Failure Drugs Sales by Country (2022-2027) & (MT)
Table 71. Europe Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. Europe Heart Failure Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 73. Asia Pacific Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 74. Asia Pacific Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 75. Asia Pacific Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 76. Asia Pacific Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 77. Asia Pacific Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 78. Asia Pacific Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 79. Asia Pacific Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 80. Asia Pacific Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 81. Asia Pacific Heart Failure Drugs Sales by Region (2016-2021) & (MT)
Table 82. Asia Pacific Heart Failure Drugs Sales by Region (2022-2027) & (MT)
Table 83. Asia Pacific Heart Failure Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 84. Asia Pacific Heart Failure Drugs Revenue by Region (2022-2027) & (US$ Million)
Table 85. Latin America Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 86. Latin America Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 87. Latin America Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 88. Latin America Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 89. Latin America Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 90. Latin America Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 91. Latin America Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 92. Latin America Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 93. Latin America Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 94. Latin America Heart Failure Drugs Sales by Country (2022-2027) & (MT)
Table 95. Latin America Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 96. Latin America Heart Failure Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Heart Failure Drugs Sales by Type (2016-2021) & (MT)
Table 98. Middle East and Africa Heart Failure Drugs Sales by Type (2022-2027) & (MT)
Table 99. Middle East and Africa Heart Failure Drugs Revenue by Type (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Heart Failure Drugs Revenue by Type (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Heart Failure Drugs Sales by Application (2016-2021) & (MT)
Table 102. Middle East and Africa Heart Failure Drugs Sales by Application (2022-2027) & (MT)
Table 103. Middle East and Africa Heart Failure Drugs Revenue by Application (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Heart Failure Drugs Revenue by Application (2022-2027) & (US$ Million)
Table 105. Middle East and Africa Heart Failure Drugs Sales by Country (2016-2021) & (MT)
Table 106. Middle East and Africa Heart Failure Drugs Sales by Country (2022-2027) & (MT)
Table 107. Middle East and Africa Heart Failure Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 108. Middle East and Africa Heart Failure Drugs Revenue by Country (2022-2027) & (US$ Million)
Table 109. Novartis Corporation Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 112. Novartis Heart Failure Drugs Product
Table 113. Novartis Recent Developments
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 117. Pfizer Heart Failure Drugs Product
Table 118. Pfizer Recent Developments
Table 119. AstraZeneca Corporation Information
Table 120. AstraZeneca Description and Major Businesses
Table 121. AstraZeneca Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 122. AstraZeneca Heart Failure Drugs Product
Table 123. AstraZeneca Recent Developments
Table 124. Hikma Corporation Information
Table 125. Hikma Description and Major Businesses
Table 126. Hikma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 127. Hikma Heart Failure Drugs Product
Table 128. Hikma Recent Developments
Table 129. Teva Corporation Information
Table 130. Teva Description and Major Businesses
Table 131. Teva Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 132. Teva Heart Failure Drugs Product
Table 133. Teva Recent Developments
Table 134. Cipla Corporation Information
Table 135. Cipla Description and Major Businesses
Table 136. Cipla Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 137. Cipla Heart Failure Drugs Product
Table 138. Cipla Recent Developments
Table 139. Merck & Co. Corporation Information
Table 140. Merck & Co. Description and Major Businesses
Table 141. Merck & Co. Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 142. Merck & Co. Heart Failure Drugs Product
Table 143. Merck & Co. Recent Developments
Table 144. Amgen Corporation Information
Table 145. Amgen Description and Major Businesses
Table 146. Amgen Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Amgen Heart Failure Drugs Product
Table 148. Amgen Recent Developments
Table 149. Roche Corporation Information
Table 150. Roche Description and Major Businesses
Table 151. Roche Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Roche Heart Failure Drugs Product
Table 153. Roche Recent Developments
Table 154. Sun Pharma Corporation Information
Table 155. Sun Pharma Description and Major Businesses
Table 156. Sun Pharma Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 157. Sun Pharma Heart Failure Drugs Product
Table 158. Sun Pharma Recent Developments
Table 159. Mylan Corporation Information
Table 160. Mylan Description and Major Businesses
Table 161. Mylan Heart Failure Drugs Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
Table 162. Mylan Heart Failure Drugs Product
Table 163. Mylan Recent Developments
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Heart Failure Drugs Distributors List
Table 167. Heart Failure Drugs Customers List
Table 168. Heart Failure Drugs Market Trends
Table 169. Heart Failure Drugs Market Drivers
Table 170. Heart Failure Drugs Market Challenges
Table 171. Heart Failure Drugs Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Heart Failure Drugs Product Picture
Figure 2. Global Heart Failure Drugs Market Share by Type in 2020 & 2027
Figure 3. ACEI Product Picture
Figure 4. Angiotensin II Receptor Blockers Product Picture
Figure 5. ARNIs Product Picture
Figure 6. Beta Blockers Product Picture
Figure 7. Aldosterone Antagonists Product Picture
Figure 8. Diuretics Product Picture
Figure 9. Global Heart Failure Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. Reduced Ejection Fraction
Figure 11. Preserved Ejection Fraction
Figure 12. Heart Failure Drugs Report Years Considered
Figure 13. Global Heart Failure Drugs Sales 2016-2027 (MT)
Figure 14. Global Heart Failure Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Heart Failure Drugs Revenue 2016-2027 (US$ Million)
Figure 16. Global Heart Failure Drugs Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 17. Global Heart Failure Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Heart Failure Drugs Sales Market Share by Region (2022-2027)
Figure 19. North America Heart Failure Drugs Sales YoY (2016-2027) & (MT)
Figure 20. North America Heart Failure Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Europe Heart Failure Drugs Sales YoY (2016-2027) & (MT)
Figure 22. Europe Heart Failure Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Asia-Pacific Heart Failure Drugs Sales YoY (2016-2027) & (MT)
Figure 24. Asia-Pacific Heart Failure Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Latin America Heart Failure Drugs Sales YoY (2016-2027) & (MT)
Figure 26. Latin America Heart Failure Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Middle East & Africa Heart Failure Drugs Sales YoY (2016-2027) & (MT)
Figure 28. Middle East & Africa Heart Failure Drugs Revenue YoY (2016-2027) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Heart Failure Drugs Sales in 2020
Figure 30. The Top 10 and Top 5 Players Market Share by Heart Failure Drugs Revenue in 2020
Figure 31. Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 32. Global Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 33. Global Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 34. Global Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 35. Global Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 36. North America Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 37. North America Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 38. North America Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 39. North America Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 40. North America Heart Failure Drugs Sales Share by Country (2016-2027)
Figure 41. North America Heart Failure Drugs Revenue Share by Country (2016-2027)
Figure 42. U.S. Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 43. Canada Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 44. Europe Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 45. Europe Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 46. Europe Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 47. Europe Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 48. Europe Heart Failure Drugs Sales Share by Country (2016-2027)
Figure 49. Europe Heart Failure Drugs Revenue Share by Country (2016-2027)
Figure 50. Germany Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 51. France Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 52. U.K. Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 53. Italy Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 54. Russia Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 55. Asia Pacific Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 56. Asia Pacific Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 57. Asia Pacific Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 58. Asia Pacific Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 59. Asia Pacific Heart Failure Drugs Sales Share by Region (2016-2027)
Figure 60. Asia Pacific Heart Failure Drugs Revenue Share by Region (2016-2027)
Figure 61. China Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 62. Japan Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 63. South Korea Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 64. India Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 65. Australia Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 66. Taiwan Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 67. Indonesia Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 68. Thailand Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 69. Malaysia Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 70. Philippines Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 71. Latin America Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 72. Latin America Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 73. Latin America Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 74. Latin America Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 75. Latin America Heart Failure Drugs Sales Share by Country (2016-2027)
Figure 76. Latin America Heart Failure Drugs Revenue Share by Country (2016-2027)
Figure 77. Mexico Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 78. Brazil Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 79. Argentina Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 80. Middle East and Africa Heart Failure Drugs Sales Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Heart Failure Drugs Revenue Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Heart Failure Drugs Sales Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Heart Failure Drugs Revenue Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Heart Failure Drugs Sales Share by Country (2016-2027)
Figure 85. Middle East and Africa Heart Failure Drugs Revenue Share by Country (2016-2027)
Figure 86. Turkey Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 87. Saudi Arabia Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 88. U.A.E Heart Failure Drugs Revenue (2016-2027) & (US$ Million)
Figure 89. Heart Failure Drugs Value Chain
Figure 90. Heart Failure Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed